Autopsy report · NCT00477230
Pivotal Clinical Study of Endoscopic Ablation for Atrial Fibrillation (AF) in Patients That Have Failed Drugs
Cause of deathFunding or business
“Study terminated based on decision of Sponsor.”
Life of this trial
- Registered 2 months after it had already started.
- Ran for about 2 years 2 months before it stopped.
- 64 participants enrolled.
- Results were posted on the registry 3 years 1 month after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 3
- Sponsor
- CardioFocus
- Sponsor type
- Industry
- Conditions
- Atrial Fibrillation
- Interventions
- Endoscopic Ablation System; Standard Anti-arrhythmic Drug (AAD) Therapy
- Participants
- 64
- Sites
- 18
- Countries
- United States
Trials that died the same way
- A Study Evaluating the Effects of GLPG3970 Given as an Oral Treatment for 12 Weeks in Adults With Active Primary Sjögren's Syndrome (pSS)
“Study was terminated based on Sponsor decision” - Valproic Acid (VPA) for Acute Kidney Injury (AKI) in Liver Transplant Patients
“Study terminated by the Sponsor” - Visual Function Tests in Age-related Macular Degeneration
“Study terminated by Sponsor” - A Study to Assess Recurrence of Actinic Keratosis in Participants Treated With Methyl Aminolevulinate Hydrochloride Cream or Vehicle Cream Who Achieved Complete Response to Treated Lesions in Earlier Study
“The study was terminated early as per Sponsor's decision” - Clinical Evaluation of Tattoo Removal Using a Novel Dual-Wavelength, Dual-Pulse Duration Laser
“Sponsor terminated study.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.